Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Use of Airway Pressure Release Ventilation (APRV) in ARDS

NCT: NCT04221737 · RECRUITING

NCT IDNCT04221737
StatusRECRUITING
Start Date2017-07-15
Completion2026-12
SponsorHospital Civil de Guadalajara (OTHER)
First posted
Last updated

Brief Summary

Airway pressure release ventilation (APRV) is a time-cycled, pressure controlled, intermittent mandatory ventilation mode with extreme inverse I:E ratios. Currently it is considered as a non-conventional ventilatory mode. The investigators aim to compare APRV with conventional mechanical ventilation (MV) in patients with acute respiratory distress syndrome (ARDS).

Frequently Asked Questions

What is Early Use of Airway Pressure Release Ventilation (APRV) in ARDS?

Early Use of Airway Pressure Release Ventilation (APRV) in ARDS is a clinical trial registered under NCT04221737. Current status: RECRUITING.

What is the status of NCT04221737?

The current status of NCT04221737 (Early Use of Airway Pressure Release Ventilation (APRV) in ARDS) is: RECRUITING.

When did Early Use of Airway Pressure Release Ventilation (APRV) in ARDS start?

Early Use of Airway Pressure Release Ventilation (APRV) in ARDS started on 2017-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑